Finian Martin
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes 11
- Parathyroid Disorders and Treatments 7
- Molecular Biology top 5%
- TGF-β signaling in diseases 14
- Renal and related cancers 13
- Connective Tissue Growth Factor Research 10
- Cancer Research top 5%
- Clinical Biochemistry top 2%
- Genetics top 5%
- Estrogen and related hormone effects 10
-
- Cancer Cells and Metastasis 8
-
- Growth Hormone and Insulin-like Growth Factors 5
- Co-authors
- Catherine GodsonMadeline MurphyDerek P. BrazilHugh R. BradyFionnuala B. HickeyHarald S. MackenzieJean McBryanSara McNally
- Journals
- Journal of Biological Chemistry (7 papers)Circulation (1 paper)The Journal of Cell Biology (1 paper)
- Partner nations
- IrelandUnited KingdomUnited States
In The Last Decade
Finian Martin
73 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 134
- Nephrology 549
- Molecular Biology 2.5k
- Cancer Research 506
- Clinical Biochemistry 174
- Genetics 653
Countries citing papers authored by Finian Martin
This map shows the geographic impact of Finian Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finian Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finian Martin more than expected).
Fields of papers citing papers by Finian Martin
This network shows the impact of papers produced by Finian Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finian Martin. The network helps show where Finian Martin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Finian Martin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 71 | |
| 2 | 2015 | 12 | |
| 3 | 2013 | 17 | |
| 4 | 2013 | 61 | |
| 5 | 2012 | 85 | |
| 6 | 2012 | 71 | |
| 7 | 2012 | 67 | |
| 8 | 2011 | 8 | |
| 9 | 2011 | 63 | |
| 10 | 2010 | 15 | |
| 11 | 2010 | 21 | |
| 12 | 2009 | 135 | |
| 13 | 2008 | 122 | |
| 14 | 2008 | 55 | |
| 15 | 2007 | 95 | |
| 16 | 2004 | 55 | |
| 17 | 2004 | 34 | |
| 18 | 2003 | 78 | |
| 19 | 1996 | 86 | |
| 20 | 1996 | 38 |
About Finian Martin
Finian Martin is a scholar working on Nephrology, Genetics and Molecular Biology, having authored 75 papers that have together received 4.0k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (14 papers), Renal and related cancers (13 papers), Chronic Kidney Disease and Diabetes (11 papers), Connective Tissue Growth Factor Research (10 papers), Estrogen and related hormone effects (10 papers), Cancer Cells and Metastasis (8 papers), Parathyroid Disorders and Treatments (7 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). The work is most often cited by research in Nephrology (549 citations), Molecular Biology (2.5k citations) and Cancer Research (506 citations). Finian Martin has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Catherine Godson, Madeline Murphy, Derek P. Brazil, Hugh R. Brady, Fionnuala B. Hickey, Harald S. Mackenzie, Jean McBryan, Sara McNally, Jillian Howlin and David Walsh. Their work appears in journals such as Journal of Biological Chemistry, Circulation and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.